👀 Copy Legendary Investors' Portfolios in One ClickCopy For Free

20 Of The Biggest Dividend-Paying, Healthcare Stocks

Published 10/02/2012, 04:56 AM
Updated 07/09/2023, 06:31 AM
NOVN
-
TTEF
-
PFE
-
TTM
-
JNJ
-
FBRT
-
BAX
-
NVS
-

The healthcare sector is of huge importance for the economy and should expect high growth due to the increasing, aging population. The whole sector has a total market capitalization of USD 38.75 billion and includes 539 stocks of which 79 pay dividends. I made a screen of the biggest dividend payesr within the healthcare sector. Below are the 20 largest dividend paying healthcare stocks, 11 of which are drug manufacturers.

Johnson & Johnson (NYSE:JNJ) has a market capitalization of $190.15 billion. The company employs 117,900 people, generates revenue of $65,030.00 million and has a net income of $9,672.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $15,993.00 million. The EBITDA margin is 24.59 percent (operating margin 19.01 percent and net profit margin 14.87 percent).

Financial Analysis: The total debt represents 17.27 percent of the company’s assets and the total debt in relation to the equity amounts to 34.39 percent. Due to the financial situation, a return on equity of 17.02 percent was realized. Twelve trailing months earnings per share reached a value of $3.14. Last fiscal year, the company paid $2.25 in form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 21.99, P/S ratio 2.92 and P/B ratio 3.29. Dividend Yield: 3.54 percent. The beta ratio is 0.54.

Long-Term Stock History Chart Of Johnson & Johnson

Long-Term Dividends History of Johnson & Johnson (JNJ)

Long-Term Dividend Yield History of Johnson & Johnson (NYSE JNJ)
Pfizer (NYSE:PFE) has a market capitalization of $187.00 billion. The company employs 103,700 people, generates revenue of $67,425.00 million and has a net income of $8,739.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $23,011.00 million. The EBITDA margin is 34.13 percent (operating margin 18.93 percent and net profit margin 12.96 percent).

Financial Analysis: The total debt represents 20.72 percent of the company’s assets and the total debt in relation to the equity amounts to 47.39 percent. Due to the financial situation, a return on equity of 10.24 percent was realized. Twelve trailing months earnings per share reached a value of $1.15. Last fiscal year, the company paid $0.80 in form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 21.74, P/S ratio 2.75 and P/B ratio 2.29. Dividend Yield: 3.54 percent. The beta ratio is 0.71.

Long-Term Stock History Chart Of Pfizer

Long-Term Dividends History of Pfizer (PFE)

Long-Term Dividend Yield History of Pfizer (NYSE PFE)
Novartis (NYSE:NVS) has a market capitalization of $149.35 billion. The company employs 123,686 people, generates revenue of $59,375.00 million and has a net income of $9,245.00 million. The firm’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $15,751.00 million. The EBITDA margin is 26.53 percent (operating margin 18.52 percent and net profit margin 15.57 percent).

Financial Analysis: The total debt represents 17.22 percent of the company’s assets and the total debt in relation to the equity amounts to 30.72 percent. Due to the financial situation, a return on equity of 14.12 percent was realized. Twelve trailing months earnings per share reached a value of $3.54. Last fiscal year, the company paid $2.25 in form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 17.43, P/S ratio 2.80 and P/B ratio 2.24. Dividend Yield: 4.05 percent. The beta ratio is 0.53.

Long-Term Stock History Chart Of Novartis

Long-Term Dividends History of Novartis (NVS)

Long-Term Dividend Yield History of Novartis (NYSE NVS)
Take a closer look at the full table of the biggest healthcare dividend stocks. The average price to earnings ratio (P/E ratio) amounts to 17.29 and forward P/E ratio is 12.10. The dividend yield has a value of 2.86 percent. Price to book ratio is 4.13 and price to sales ratio 2.74. The operating margin amounts to 21.94 percent and the beta ratio is 0.63. The average stock has a debt to equity ratio of 0.61.

Here is the full table with some fundamentals (TTM):

20 Of The Biggest Healthcare Dividend Payer
Related stock ticker symbols:
JNJ, PFE, NVS, MRK, SNY, GSK, ABT, NVO, AMGN, AZN, UNH, BMY, LLY,
MDT, TEVA, BAX, AGN, COV, FMS, TMO

Latest comments

Loading next article…
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.